Related Experiment Videos
In vitro response of Enterobacter to ampicillin.
Antimicrobial Agents and Chemotherapy
|October 1, 1979
Summary
Three Enterobacter strains showed ampicillin resistance, with mutations leading to enhanced antibiotic inactivation and cross-resistance to other beta-lactams. This explains discrepancies in antibiotic testing methods.
Area of Science:
- Microbiology
- Bacterial resistance mechanisms
Background:
- Enterobacter species are known to develop antibiotic resistance.
- Ampicillin resistance in bacteria can be influenced by environmental factors and genetic mutations.
Purpose of the Study:
- To investigate the mechanisms of ampicillin resistance in three Enterobacter strains.
- To characterize the antibiotic inactivation capabilities of resistant mutants.
- To explain observed discrepancies in antibiotic susceptibility testing.
Main Methods:
- Studying Enterobacter strains' response to ampicillin across different media.
- Selecting and analyzing ampicillin-resistant mutants.
- Utilizing biological assays to measure antibiotic inactivation.
- Comparing results with traditional broth dilution and automated procedures.
Main Results:
- A baseline ampicillin resistance was observed, dependent on the growth medium.
- High-level mutational resistance occurred at a frequency of 10(-5) to 10(-7).
- Two distinct mutant classes emerged: one with significantly enhanced antibiotic inactivation, the other similar to the wild type.
- Both mutant classes exhibited cross-resistance to other beta-lactam antibiotics.
Conclusions:
- Mutations in Enterobacter can lead to significant ampicillin inactivation and broad beta-lactam cross-resistance.
- The characterized resistance mechanisms help reconcile differences between standard and automated antibiotic testing methods.
- Understanding these resistance patterns is crucial for effective antimicrobial therapy and diagnostics.